Researcher
Annelies Verbiest
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2016 → 30 Sep 2020
Projects
1 - 1 of 1
- Molecular profiling of clear-cell renal cell carcinoma and prediction of response to targeted therapies against the vascular endothelial growth factor receptor, immune checkpoint inhibitors and mTOR inhibitors in the metastatic setting.From1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships, Nonprofit institution or equivalents
Publications
1 - 10 of 22
- Pushing the limits of metastasis-directed treatment in metastatic renal cell carcinoma in the era of targeted therapy(2020)
Authors: Murat Akand, Annelies Verbiest, Benoit Beuselinck, Maarten Albersen, Eduard Roussel, Hendrik Van Poppel, Steven Joniau
- Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinoma(2020)
Authors: Eduard Roussel, Annelies Verbiest, Ben Van Cleynenbreugel, Hendrik Van Poppel, Steven Joniau, Benoit Beuselinck, Maarten Albersen
Pages: 493 - 499 - MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets(2020)
Authors: Annelies Verbiest, Maarten Albersen, Marcella Baldewijns, Annouschka Laenen, Eduard Roussel, Patrick Schöffski, Agnieszka Wozniak, Benoit Beuselinck
- Bone metastasis is associated with poor prognosis in metastatic papillary renal cell carcinoma patients treated with first agent angiogenesis inhibitors(2020)
Authors: Annelies Verbiest, Marcella Baldewijns, Eduard Roussel, Annouschka Laenen, Maarten Albersen, Benoit Beuselinck
- Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma(2020)
Authors: Eduard Roussel, Annelies Verbiest, Benoit Beuselinck, Maarten Albersen
Pages: 523 - 529 - Molecular classification of clear-cell renal cell carcinoma and prediction of response to systemic therapies(2020)
Authors: Annelies Verbiest, Benoit Beuselinck, Diether Lambrechts
- Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib(2020)
Authors: Benoit Beuselinck, Annelies Verbiest, Maxime Vanmechelen, Eduard Roussel, Maarten Albersen, Marcella Baldewijns, Diether Lambrechts
- Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors(2020)
Authors: Benoit Beuselinck, Marcella Baldewijns, Annouschka Laenen, Annelies Verbiest, Eduard Roussel, Maarten Albersen, Vincent Vandecaveye
Pages: 818 - 824 - THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN THE CONTEMPORARY MANAGEMENT OF METASTATIC KIDNEY CANCER: PREDICTIVE FACTORS FOR SURGICAL COMPLICATIONS AND ONCOLOGICAL SURVIVAL(2020)
Authors: Eduard Roussel, Annelies Verbiest, Uros Milenkovic, Wouter Everaerts, Ben Van Cleynenbreugel, Gaëtan Devos, Hendrik Van Poppel, Steven Joniau, Benoit Beuselinck, Maarten Albersen
Pages: E200 - E200 - Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitors(2019)
Authors: Hans Wildiers, Annelies Verbiest, Herlinde Dumez, Evelyne Lerut, Steven Pans, Maarten Albersen, Benoit Beuselinck
Pages: 414 - 423